PHIO Q4 2024 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$48,000

Balance Sheet

Total Assets

$6M

Total Liabilities

$1M

Stockholders' Equity

$5M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$43,000	+100.0%
Operating Income	-$2M	-$2M	+5.6%
Net Income	-$2M	-$2M	+14.2%